Increased chromatin accessibility drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 130 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 130 samples: 36 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancerCell reports · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE252902_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1063199 and SRA study SRP482785. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 101 samples.
How we read this: 36 replicated groups read from 130 sample titles; they account for 101 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8008789 VCaP, DMSO_1 VCaP, DMSO
- GSM8008790 VCaP, DMSO_2 VCaP, DMSO
- GSM8008791 VCaP, DMSO_3 VCaP, DMSO
- GSM8008792 VCaP, ENZ_1 VCaP, ENZ
- GSM8008793 VCaP, ENZ_2 VCaP, ENZ
- GSM8008794 VCaP, ENZ_3 VCaP, ENZ
- GSM8008795 VCaP16_1 VCaP16
- GSM8008796 VCaP16_2 VCaP16
- GSM8008797 VCaP16_3 VCaP16
- GSM8008798 VCaP, DMSO_1 VCaP, DMSO
- GSM8008799 VCaP, DMSO_2 VCaP, DMSO
- GSM8008800 VCaP, DMSO_3 VCaP, DMSO
- GSM8008801 VCaP, ENZ_1 VCaP, ENZ
- GSM8008802 VCaP, ENZ_2 VCaP, ENZ
- GSM8008803 VCaP, ENZ_3 VCaP, ENZ
- GSM8008804 VCaP16_1 VCaP16
- GSM8008805 VCaP16_2 VCaP16
- GSM8008806 VCaP16_3 VCaP16
- GSM8008807 VCaP16, DMSO_1 VCaP16, DMSO
- GSM8008808 VCaP16, DMSO_2 VCaP16, DMSO
- GSM8008809 VCaP16, DMSO_3 VCaP16, DMSO
- GSM8008810 VCaP16, ARD_1 VCaP16, ARD
- GSM8008811 VCaP16, ARD_2 VCaP16, ARD
- GSM8008812 VCaP16, ARD_3 VCaP16, ARD
- GSM8008813 VCaP16, siV7_1 VCaP16, siV7
- GSM8008814 VCaP16, siV7_2 VCaP16, siV7
- GSM8008815 VCaP16, siV7_3 VCaP16, siV7
- GSM8008816 VCaP16, siEx1_1 VCaP16, siEx1
- GSM8008817 VCaP16, siEx1_2 VCaP16, siEx1
- GSM8008818 VCaP16, siEx1_3 VCaP16, siEx1
- GSM8008819 VCaP16, siEx7_1 VCaP16, siEx7
- GSM8008820 VCaP16, siEx7_2 VCaP16, siEx7
- GSM8008821 VCaP16, siEx7_3 VCaP16, siEx7
- GSM8008822 VCaP16, siNTC_AR_1 VCaP16, siNTC_A
- GSM8008823 VCaP16, siNTC_AR_2 VCaP16, siNTC_A
- GSM8008824 VCaP16, siNTC_AR_3 VCaP16, siNTC_A
- GSM8008825 VCaP16, siFOXA1_1 VCaP16, siFOXA1
- GSM8008826 VCaP16, siFOXA1_2 VCaP16, siFOXA1
- GSM8008827 VCaP16, siNTC_1, FOXA1
- GSM8008828 VCaP16, siNTC_2, FOXA1
+ 90 more — browse all 130 samples with per-sample file links →
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing
- GSE287902 BPTF regulstes androgen receptor activity by enhancing chromatin accessibility and stabilizing the AR-FOXA1 interaction [Cut&Run] 40 samples shares accessibility, chromatin, androgen, receptor
- GSE268091 Mechano-osmotic signals control chromatin state and fate transitions in pluripotent stem cells 61 samples shares transition, chromatin
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.